Jessica Merrill
With the loss of its top-selling drug – the attention deficit/hyperactivity drug Adderall XR (amphetamine extended release) – to generic...
For Shire, Life After Adderall XR? Yes
Shire has scaled its Adderall XR patent cliff, replenishing lost blockbuster sales with revenues from niche products, smart life-cycle management, and some good-old-fashioned luck. IN VIVO interviews CEO Angus Russell.